BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30461131)

  • 1. Atypical ductal hyperplasia on core needle biopsy: Development of a predictive model stratifying carcinoma upgrade risk on excision.
    Salagean ED; Slodkowska E; Nofech-Mozes S; Hanna W; Parra-Herran C; Lu FI
    Breast J; 2019 Jan; 25(1):56-61. PubMed ID: 30461131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.
    Williams KE; Amin A; Hill J; Walter C; Inciardi M; Gatewood J; Redick M; Wick J; Hunt S; Winblad O
    Acad Radiol; 2019 Jul; 26(7):893-899. PubMed ID: 30318287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.
    Chen LY; Hu J; Tsang JYS; Lee MA; Ni YB; Chan SK; Tse GMK
    Histopathology; 2019 Sep; 75(3):320-328. PubMed ID: 31013355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
    Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
    Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.
    Co M; Kwong A; Shek T
    Int J Surg; 2018 Jan; 49():27-31. PubMed ID: 29146271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical ductal hyperplasia: Clinicopathologic factors are not predictive of upgrade after excisional biopsy.
    Sutton T; Farinola M; Johnson N; Garreau JR
    Am J Surg; 2019 May; 217(5):848-850. PubMed ID: 30611396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
    Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
    Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model.
    Linsk A; Mehta TS; Dialani V; Brook A; Chadashvili T; Houlihan MJ; Sharma R
    Breast J; 2018 Mar; 24(2):115-119. PubMed ID: 28833923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy.
    Ko E; Han W; Lee JW; Cho J; Kim EK; Jung SY; Kang MJ; Moon WK; Park IA; Kim SW; Kim KS; Lee ES; Min KH; Kim SW; Noh DY
    Breast Cancer Res Treat; 2008 Nov; 112(1):189-95. PubMed ID: 18060577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.
    Chae BJ; Lee A; Song BJ; Jung SS
    World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is bigger better? Twenty-year institutional experience of atypical ductal hyperplasia discovered by core needle biopsy.
    Weiss JB; Do WS; Forte DM; Sheldon RR; Childers CK; Sohn VY
    Am J Surg; 2019 May; 217(5):906-909. PubMed ID: 30771862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Breast Magnetic Resonance Imaging in Women Diagnosed With Atypical Ductal Hyperplasia at Core Needle Biopsy Helps Select Women for Surgical Excision.
    Amitai Y; Menes T; Golan O
    Can Assoc Radiol J; 2018 Aug; 69(3):240-247. PubMed ID: 29958833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
    Wagoner MJ; Laronga C; Acs G
    Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up.
    Rizzo M; Linebarger J; Lowe MC; Pan L; Gabram SG; Vasquez L; Cohen MA; Mosunjac M
    J Am Coll Surg; 2012 Mar; 214(3):280-7. PubMed ID: 22244207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens.
    Rageth CJ; Rubenov R; Bronz C; Dietrich D; Tausch C; Rodewald AK; Varga Z
    Breast Cancer; 2019 Jul; 26(4):452-458. PubMed ID: 30591993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of upgrade for atypical ductal hyperplasia detected on magnetic resonance imaging-guided biopsy: a study of 100 cases from four academic institutions.
    Khoury T; Li Z; Sanati S; Desouki MM; Chen X; Wang D; Liu S; Karabakhtsian R; Kumar P; Reig B
    Histopathology; 2016 Apr; 68(5):713-21. PubMed ID: 26291517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates.
    Tozbikian G; George M; Zynger DL
    Diagn Pathol; 2019 Jun; 14(1):69. PubMed ID: 31253155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.
    Peña A; Shah SS; Fazzio RT; Hoskin TL; Brahmbhatt RD; Hieken TJ; Jakub JW; Boughey JC; Visscher DW; Degnim AC
    Breast Cancer Res Treat; 2017 Jul; 164(2):295-304. PubMed ID: 28474262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipsilateral and Concurrent Breast Cancer and Atypical Ductal Hyperplasia: Does Atypia Also Need Surgical Excision?
    Amin AL; Fan F; Winblad OD; Larson KE; Wagner JL
    Ann Surg Oncol; 2020 Nov; 27(12):4786-4794. PubMed ID: 32705514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.